WEGOVY tablets semaglutide 9mg

Regular price
142.000 KD
Regular price
Sale price
142.000 KD
Subtotal: 142.000 KD
Please hurry! Only 58 left in stock
SKU: OWEGTS9MG
Availability: In Stock

No discount code is applicable for this product.

10 customers are viewing this product
Free Shipping

Free standard shipping on all orders above 25KWD

Free Returns
Learn More.
WEGOVY tablets semaglutide 9mg

WEGOVY tablets semaglutide 9mg

142.000 KD

WEGOVY tablets semaglutide 9mg

142.000 KD

WEGOVY® Tablets (Semaglutide 9 mg) is the third dose-escalation stage of oral Wegovy therapy for chronic weight management and cardiovascular risk reduction in eligible adults. It belongs to the GLP-1 receptor agonist class and is typically prescribed after completing 30 days each of the 1.5 mg and 4 mg doses. The 9 mg dose helps patients gradually adapt to treatment before advancing to the maintenance dose of 25 mg daily.

Synonym Names

  • Wegovy 9 mg Tablet
  • Oral Semaglutide 9 mg
  • Semaglutide Weight Loss Tablet
  • GLP-1 Receptor Agonist Tablet
  • Weight Management Medication

Key Ingredients

  • Semaglutide – 9 mg
  • SNAC (Sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) absorption enhancer
  • Pharmaceutical excipients as approved by the manufacturer.

Benefits

  • Helps reduce appetite and hunger
  • Promotes feelings of fullness after meals
  • Supports medically supervised weight loss
  • May help reduce food cravings
  • Assists with long-term weight management
  • Supports cardiovascular risk reduction in eligible adults
  • Provides a needle-free alternative to injectable semaglutide therapies.

How Does It Work

Semaglutide mimics the naturally occurring hormone GLP-1 (Glucagon-Like Peptide-1). It works by acting on appetite-regulating centers in the brain, slowing gastric emptying, and increasing satiety, helping users consume fewer calories and manage their weight more effectively.

Why Choose

  • Convenient once-daily oral tablet
  • No injections required
  • Gradual dose-escalation approach improves tolerability
  • Clinically studied for weight management
  • Helps prepare patients for the 25 mg maintenance dose
  • Suitable for patients who prefer tablets over injections.

Suitable For

  • Adults with obesity (BMI ≥30 kg/m²)
  • Adults who are overweight (BMI ≥27 kg/m²) with at least one weight-related condition
  • Patients progressing from the 4 mg oral dose
  • Individuals prescribed oral semaglutide by a healthcare professional.

How To Use

  • Take 1 tablet once daily in the morning on an empty stomach.
  • Swallow the tablet whole with up to 120 mL (4 ounces) of plain water.
  • Wait at least 30 minutes before eating, drinking, or taking other medications.
  • Do not split, crush, chew, or dissolve the tablet.

Recommended Dosage

Typical oral Wegovy tablet schedule:

Treatment Period Daily Dose
Days 1–30 1.5 mg
Days 31–60 4 mg
Days 61–90 9 mg
Day 91 onward 25 mg

The 9 mg dose is generally used during Days 61–90 before progressing to the maintenance dose, as tolerated.

Precautions

  • Prescription-only medication.
  • Inform your healthcare provider if you have a history of pancreatitis, gallbladder disease, kidney disease, or diabetic retinopathy.
  • Avoid use in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2).
  • Consult a healthcare professional before use during pregnancy or breastfeeding.
  • Follow the prescribed dosage schedule carefully.

Side Effects

Common side effects may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain
  • Indigestion
  • Headache
  • Fatigue

Gastrointestinal side effects may become more noticeable during dose escalation to 9 mg.

Additional Information

  • Available tablet strengths include 1.5 mg, 4 mg, 9 mg, and 25 mg.
  • The 9 mg tablet is an escalation dose and not the final maintenance dose.
  • Community experiences vary: some users report increased appetite control and weight loss after moving to 9 mg, while others notice minimal changes until reaching higher doses.

FAQs

What is Wegovy 9 mg used for?

Wegovy 9 mg is used as an intermediate dose during oral semaglutide treatment for chronic weight management and cardiovascular risk reduction in eligible adults.

Is 9 mg the maintenance dose?

No. The recommended maintenance dose for oral Wegovy is 25 mg once daily. The 9 mg dose is a transition step before reaching maintenance therapy.

Can I stay on 9 mg instead of increasing to 25 mg?

Only your healthcare provider can determine the most appropriate dose. Some patients may remain on lower doses based on tolerability and clinical response.

What should I do if I miss a dose?

Skip the missed dose and take your next scheduled dose the following day. Do not take two doses on the same day.

Will I notice more weight loss at 9 mg?

Many users report greater appetite suppression and weight-loss effects at 9 mg compared with 1.5 mg or 4 mg, although responses vary significantly between individuals.

Disclaimer

The content is purely informative and educational in nature and should not be construed as medical advice. Please use the content only in consultation with an appropriate certified medical or healthcare professional. WEGOVY® (semaglutide) is a prescription medication and should only be used under medical supervision. Always read the prescribing information and follow your healthcare provider's instructions.



Cash on Delivery

Cash on Delivery

100% Original Products

100% Original Products

Secure Payments

Secure Payments

7 Days Returns

7 Days Returns

Related Products